There appeared to be an increasing trend of serum biomarker concentrations, as ovarian lesions progressed from benign to malignant.
← all excerpts
Retrospective Study of the Epidemiology, Pathology, and Therapeutic Management in Patients With Mucinous Ovarian Tumors.
1
—
—